MedTrace Logo

The Captivator EMR Registry

NCT02482701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 291

Last updated 2018-03-07

No results posted yet for this study

Summary

To confirm performance of the Captivator™ EMR device for resection of early neoplasia in Barrett's Esophagus.

Conditions

  • Barrett's Esophagus

Interventions

DEVICE

Captivator™ EMR

The Captivator ™ EMR Device is indicated for endoscopic mucosal resection (EMR) in the upper gastrointestinal (GI) tract.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Jacques Bergman, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-05-31
Completion
2017-06-30

Countries

  • United States
  • Belgium
  • Canada
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482701 on ClinicalTrials.gov